Annual Report 2003 - Nobel Biocare Corporate

NOBEL BIOCARE ANNUAL REPORT 200351Report of the Group Auditors to the Board of Directorsof Nobel Biocare Holding AGAs group auditors, we have audited the consolidatedfinancial statements (income statement, balancesheet, statement of changes in equity, cash flowstatement and notes on page 35 to page 50) ofNobel Biocare Holding AG for the year ended31 December 2003.These consolidated financial statements arethe responsibility of the Board of Directors.Our responsibility is to express an opinion onthese consolidated financial statements based onour audits. We confirm that we meet the legalrequirements concerning professional qualificationand independence.Our audit was conducted in accordance withauditing standards promulgated by the Swissprofession and with the International Standardson Auditing (ISA), which require that an audit beplanned and performed to obtain reasonableassurance about whether the consolidated financialstatements are free from material misstatement.We have examined on a test basis evidencesupporting the amounts and disclosures in thefinancial statements. We have also assessed theaccounting principles used, significant estimatesmade and the overall financial statement presentation.We believe that our audit provides a reasonablebasis for our opinion.In our opinion, the consolidated financial statementsgive a true and fair view of the financialposition, the results of operations and the cashflows in accordance with the International FinancialReporting Standards (IFRS) and comply withSwiss law.We recommend that the consolidated financialstatements submitted to you be approved.KPMG Fides PeatErik WillemsDutch Chartered AccountantAnders IvdalAuthorized Public Accountant in SwedenAuditor in ChargeZurich, 22 March 2004